Home/Filings/4/0001415889-25-007663
4//SEC Filing

LIPPS RANDALL A 4

Accession 0001415889-25-007663

CIK 0000926326other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:25 PM ET

Size

8.9 KB

Accession

0001415889-25-007663

Insider Transaction Report

Form 4
Period: 2025-03-08
LIPPS RANDALL A
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2025-03-08+188,794341,620 total
  • Tax Payment

    Common Stock

    2025-03-08$36.99/sh18,571$686,941323,049 total
Holdings
  • Common Stock

    (indirect: By Trust)
    8,051
  • Common Stock

    (indirect: By Trust)
    355,861
Footnotes (4)
  • [F1]Shares held in trust with Mr. Lipps' wife.
  • [F2]Shares held in trust for the benefit of Mr. Lipps' children.
  • [F3]Reflects performance-based restricted stock units that were previously granted on February 27, 2024, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 8, 2025 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 188,794 performance-based restricted stock units (176% of target) of which 25% vested upon the determination date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively).
  • [F4]Reflects withholding of shares to cover taxes due in connection with the vesting of performance-based restricted stock units

Issuer

OMNICELL, INC.

CIK 0000926326

Entity typeother

Related Parties

1
  • filerCIK 0001227556

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:25 PM ET
Size
8.9 KB